Patel Sanjiv — SEC insider filings

SEC reporting owner CIK 1816210. 32 insider filings on record with FilingPulse; latest filed 2026-11-20.

Transaction summary — filings shown

Covers all 32 filings on record, filed 2020-12-15 to 2026-11-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Relay Therapeutics, Inc. (RLAY)President and CEO, Director30—39 legs · 1,582,252 sh · $17,508,50562
PROTHENA CORP PUBLIC LTD CO (PRTA)Director2——2

Insider filings — Patel Sanjiv

FiledFormIssuerReported transactionsSource
2026-11-204Relay Therapeutics, Inc. (RLAY)Sale (S): 48,202 @ $16.13EDGAR
2026-10-084Relay Therapeutics, Inc. (RLAY)Sale (S): 48,199 @ $18.10EDGAR
2026-09-094Relay Therapeutics, Inc. (RLAY)Sale (S): 48,199 @ $18.94EDGAR
2026-08-184Relay Therapeutics, Inc. (RLAY)Sale (S): 48,199 @ $20.33EDGAR
2026-07-084Relay Therapeutics, Inc. (RLAY)Grant/award (A): 3,056 @ $6.95 · Sale (S): 48,199 @ $19.58EDGAR
2026-01-154Relay Therapeutics, Inc. (RLAY)Grant/award (A): 1,450,000 (derivative) @ $0EDGAR
2026-01-074Relay Therapeutics, Inc. (RLAY)Grant/award (A): 994 @ $2.99 · Sale (S): 43,168 @ $7.82EDGAR
2025-11-044Relay Therapeutics, Inc. (RLAY)Sale (S): 62,073 @ $7EDGAR
2025-07-104Relay Therapeutics, Inc. (RLAY)Sale (S): 42,740 @ $3.57 · Sale (S): 18,639 @ $3.57EDGAR
2025-07-014Relay Therapeutics, Inc. (RLAY)Grant/award (A): 5,000 @ $2.94EDGAR
2025-04-244Relay Therapeutics, Inc. (RLAY)Sale (S): 42,769 @ $2.97 · Sale (S): 18,653 @ $2.97EDGAR
2025-02-134Relay Therapeutics, Inc. (RLAY)Sale (S): 140,182 @ $3.85 · Grant/award (A): 332,465 @ $0 · Sale (S): 75,324 @ $3.70EDGAR
2025-01-234Relay Therapeutics, Inc. (RLAY)Sale (S): 125,000 @ $4.52 · Sale (S): 125,000 @ $4.80 · Sale (S): 125,000 @ $4.78EDGAR
2025-01-144Relay Therapeutics, Inc. (RLAY)Grant/award (A): 1,105,000 (derivative) @ $0EDGAR
2024-12-184Relay Therapeutics, Inc. (RLAY)Sale (S): 100,000 @ $5EDGAR
2024-07-294Relay Therapeutics, Inc. (RLAY)Option exercise (M): 50,000 @ $5.04 · Sale (S): 50,000 @ $9.16 · Option exercise (M): 36,706 @ $5.04 · Sale (S): 36,706 @ $9.07 · Option exercise (M): 50,000 (derivative) @ $0 · Option exercise (M): 36,706 (derivative) @ $0EDGAR
2024-07-014Relay Therapeutics, Inc. (RLAY)Grant/award (A): 2,108 @ $5.54EDGAR
2024-01-184Relay Therapeutics, Inc. (RLAY)Grant/award (A): 762,360 @ $0EDGAR
2023-09-294Relay Therapeutics, Inc. (RLAY)Grant/award (A): 1,662 @ $10.68EDGAR
2023-02-094Relay Therapeutics, Inc. (RLAY)Option exercise (M): 14,000 @ $5.04 · Sale (S): 14,000 @ $21.45 · Option exercise (M): 14,000 @ $5.04 · Sale (S): 14,000 @ $20.98 · Option exercise (M): 14,000 @ $5.04 · Sale (S): 14,000 @ $20.55 · +3 moreEDGAR
2023-01-194Relay Therapeutics, Inc. (RLAY)Option exercise (M): 28,000 @ $5.04 · Sale (S): 28,000 @ $20.23 · Option exercise (M): 28,000 @ $5.04 · Sale (S): 28,000 @ $20.87 · Option exercise (M): 28,000 @ $5.04 · Sale (S): 28,000 @ $20.02 · +5 moreEDGAR
2022-11-104Relay Therapeutics, Inc. (RLAY)Option exercise (M): 14,000 @ $4.12 · Sale (S): 14,000 @ $20.18 · Option exercise (M): 18,175 @ $4.12 · Sale (S): 18,175 @ $20 · Option exercise (M): 9,825 @ $5.04 · Sale (S): 9,825 @ $20 · +3 moreEDGAR
2022-10-134Relay Therapeutics, Inc. (RLAY)Option exercise (M): 14,000 @ $4.12 · Sale (S): 14,000 @ $21.36 · Option exercise (M): 14,000 @ $4.12 · Sale (S): 14,000 @ $21.18 · Option exercise (M): 14,000 @ $4.12 · Sale (S): 14,000 @ $20.58 · +3 moreEDGAR
2022-09-154Relay Therapeutics, Inc. (RLAY)Option exercise (M): 14,000 @ $4.12 · Sale (S): 14,000 @ $25.45 · Option exercise (M): 14,000 @ $4.12 · Sale (S): 14,000 @ $23.47 · Option exercise (M): 14,000 @ $4.12 · Sale (S): 14,000 @ $23.80 · +3 moreEDGAR
2022-07-084Relay Therapeutics, Inc. (RLAY)Grant/award (A): 814 @ $14.24EDGAR
2022-05-274PROTHENA CORP PUBLIC LTD CO (PRTA)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2022-04-144Relay Therapeutics, Inc. (RLAY)Option exercise (M): 28,000 @ $4.12 · Sale (S): 28,000 @ $31.80 · Option exercise (M): 14,000 @ $4.12 · Sale (S): 14,000 @ $31.96 · Option exercise (M): 14,000 @ $5.04 · Sale (S): 14,000 @ $31.94 · +9 moreEDGAR
2022-01-314Relay Therapeutics, Inc. (RLAY)Grant/award (A): 527,140 (derivative) @ $0EDGAR
2022-01-074Relay Therapeutics, Inc. (RLAY)Grant/award (A): 658 @ $26.10EDGAR
2021-05-214PROTHENA CORP PUBLIC LTD CO (PRTA)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2021-03-264Relay Therapeutics, Inc. (RLAY)Gift (G): 150,000 @ $0 · Gift (G): 150,000 @ $0 · Grant/award (A): 325,000 (derivative) @ $0EDGAR
2020-12-154Relay Therapeutics, Inc. (RLAY)Grant/award (A): 753,804 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1816210 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs